Christina Chin is anticipating the Aug. 15 opening of the romantic comedy “Crazy Rich Asians” and the insights the film offers into the Asian American second-generation experience.
The film, based on the book of the same name by Kevin Kwan, is the first from a major Hollywood studio to feature an entirely Asian cast in a present-day story since the release 25 years ago of “The Joy Luck Club.”
Chin, who has previewed the film, notes that the story it tells goes beyond money and wealth to highlight universal themes about love, friendship and negotiating family dynamics “that transcend ethnic and racial boundaries.”
The assistant professor of sociology is co-author of a widely reported 2017 study “Tokens on the Small Screen” about how Asian Americans and Pacific Islanders remain underrepresented on television. She and scholars from five other universities collaborated on the study, a 10-year follow-up to and expansion of an earlier study of Asian Americans and Pacific Islanders on prime-time series television.
Chin’s teaching and scholarly research interests include immigration, racial and ethnic identity, youth and popular culture. Chin is co-editor of "Asian American Sporting Cultures" (NYU Press -2016). Chin earned her doctorate at UCLA. Prior to joining the Cal State Fullerton faculty, she was a postdoctoral fellow for the Asian American Studies Department at the University of Illinois, Urbana-Champaign.
“This feeling of being an outsider in both worlds not only struck a deep personal cord in my own lived experience, but it could not be captured in a film with white actors.”,"With successful shows like “Master of None" & "Fresh Off the Boat” ... it may seem that Asian Americans are making greater strides on TV. Yet, when we take a deeper look at the larger TV landscape, we start to see that these shows are the exception ...”
Andrew Ching is a professor in the Carey Business School at the Johns Hopkins University, where he is jointly appointed to the Department of Economics and the Bloomberg School of Public Health. He is currently serving as an Associate Editor for Management Science, and a member of editorial boards for Marketing Science and Journal of Marketing Research. His research focuses on developing new empirical structural models and estimation methods to understand the forward-looking, strategic, learning and bounded rational behavior of consumers and firms. He has applied these methods to several industries including prescription drugs, nursing homes, payment methods, retail banking, peer-to-peer lending, and video games. He has published in Econometrica, Mangement Science, Marketing Science, Journal of Banking and Finance, Journal of Applied Econometrics, and others. He has received Young Economist Award from the European Economic Association, Honorable Mention of Dick Wittink Prize Award, and several major research grants from Social Sciences and Humanities Research Council in Canada.
Joyce Chu, Ph.D., is a Professor at Palo Alto University. She earned her B.A. and M.A. in psychology at Stanford University, her Ph.D. in clinical psychology from the University of Michigan, and did a postdoctoral fellowship at the University of California, San Francisco. Dr. Chu co-leads the Multicultural Suicide and Ethnic Minority Mental Health Research Groups at PAU, and is also Director of the Diversity and Community Mental Health (DCMH) emphasis which trains future psychologists to work with underserved populations in the public mental health sector. Under her leadership, the DCMH emphasis received awards for innovative practices in graduate education in psychology in 2011 by both the American Psychological Association Board of Educational Affairs, and the National Council of Schools and Programs of Professional Psychology. Dr. Chu also co-directs PAU’s Center for Excellence in Diversity, which was founded in 2010 by Dr. Stanley Sue. At PAU, she is an associated researcher with the Center for LGBTQ Evidence-based Applied Research Group.
Dr. Chu’s work is focused around depression and suicide in ethnic minority adult and geriatric populations, particularly in Asian Americans. Her work is community-collaborative and aims to understand barriers to service use and develop culturally congruent outreach and service options for Asian Americans and other underserved communities. She has an interest in advancing the assessment and prevention of suicide for cultural minority populations, and has published a cultural theory and model of suicide with her collaborators Peter Goldblum and Bruce Bongar. As part of this work, she and her colleagues have developed a tool to assist clinicians in accounting for cultural influences on suicide risk.
In 2012, Dr. Chu received the APA Division 12 Samuel M. Turner Early Career Award for Distinguished Contributions to Diversity in Clinical Psychology. In 2013, she was awarded the AAPA Early Career Award from the Asian American Psychological Association (AAPA).
"We don't have a definitive data on what the mental health effects would be. But we certainly know that some of the triggers for mental health issues are being activated by the current situation — for example, social isolation, financial stress and an astounding number of people with loss of income."
Dr. Jerold Chun is professor and senior vice president of Neuroscience Drug Discovery at SBP. He completed his M.D. and Ph.D. degrees at Stanford University. He studies development and diseases of the brain.
“Our fundamental studies of how the brain develops and changes over time have opened up two totally new ways of looking at neurological disease, and we’re hopeful that will lead to better treatments for Alzheimer’s, multiple sclerosis and hydrocephalus.”
Colleen Cicchetti, PhD, is a pediatric psychologist at Ann & Robert H. Lurie Children's Hospital of Chicago and an Assistant Professor in Psychiatry and Behavioral Sciences at Northwestern University Feinberg School of Medicine. She is the Executive Director of the Lurie Children's Center for Childhood Resilience, which promotes access to high quality mental health services for children and adolescents statewide through clinical service, research, training, advocacy, and policy reform. She is a leader in trauma-informed care, training staff in the Chicago Public Schools on how to help youth who have experienced trauma or have other mental health issues. She was awarded the Public Educator of the Year award by the National Alliance on Mental Illness.
M. Dolores Cimini is a New York State licensed psychologist who has provided leadership for comprehensive efforts in research-to-practice translation at the University at Albany since 1992 with over $9 million in support from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute on Drug Abuse (NIDA), Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Education, U.S. Department of Justice, and New York State Office of Addiction Services and Supports. The screening and brief intervention program developed by Dr. Cimini, the STEPS Comprehensive Alcohol Screening and Brief Intervention Program, has earned 13 national awards for best practices and innovation in behavioral health care.
Cimini is the director of the Middle Earth Peer Assistance Program at UAlbany, an agency recognized as a model/exemplary program in alcohol and other drug prevention by both the U.S. Department of Education and the Center for Substance Abuse Prevention, U.S. Department of Health and Human Services. She has published two books and numerous professional articles in both national and international refereed journals in the alcohol and substance use field and has earned two awards for excellence from the White House for her contributions to STEM mentoring. Cimini is a member of the Commission on Accreditation of the American Psychological Association and was the Past Chair of the APA Board for the Advancement of Psychology in the Public Interest, where she has had leadership for reviewing and disseminating APA’s practice standards focused on serving diverse and underrepresented groups and the addressing of issues related to psychology and social justice.
"It's so important for a project like this to occur, focusing on secondary education because how people intervene with young people at this age can really impact the rest of their lives."
Dr. Dolores Cimini says college students engage in high risk drinking and drug use, to a large extent, due to peer pressure. Cimini, says students are also experiencing freedom from their parents for the first time.
Joseph J. Ciotola, M.D., is a top rated orthopedic surgeon at Orthopedics and Joint Replacement at Mercy Medical Center. Board Certified, Dr. Ciotola’s extensive expertise in anterior hip replacement makes him one of the most sought-after orthopedic surgeons in the Baltimore region for hip replacement.
Dr. Ciotola also specializes in knee replacement and knee resurfacing using MAKO® robotic arm technology, ACL reconstruction and shoulder/upper extremity surgeries including total shoulder replacement and the LRTI procedure to relieve arthritis of the thumb.
Dr. Joseph Ciotola’s dedication to providing advanced orthopedic techniques helped bring anterior hip replacement to Orthopedics and Joint Replacement at Mercy. Dr. Ciotola, who is one of the first orthopedic surgeons in Baltimore to perform anterior hip replacement, teaches orthopedic surgeons throughout the country how to perform this minimally invasive approach to hip replacement. Many of his patients have expressed their gratitude and satisfaction by recommending Dr. Ciotola to family, friends and even strangers who are in need of a hip replacement.
Dr. Joseph Ciotola is dedicated to providing his patients the best orthopedic care possible. Patients turn to Dr. Ciotola for his clinical expertise when they have hip or knee pain. His great compassion and concern for helping relieve their pain provides patients with the confidence that they will be able to return to their daily routines. Dr. Ciotola works individually with patients to develop the best treatment options to help with the return to normal activities.
Kevin Cokley's research can be broadly categorized in the area of African American psychology, with a focus on racial and ethnic identity development, academic motivation, and academic achievement. A theme of much of his research is understanding the psychological and environmental factors that impact African American student achievement. Cokley's research and scholarship have led him to challenge the notion that African American students are anti-intellectual, and to critically re-examine the impact of racial and ethnic identity and gender on academic achievement. Recently Cokley has started exploring the impostor phenomenon and its relationship to mental health and academic outcomes among ethnic minority students.
Cokley's publications have appeared in professional journals such as the Journal of Counseling Psychology, Journal of Black Psychology, Cultural Diversity and Ethnic Minority Psychology, Individual Differences and Personality, Measurement and Evaluation in Counseling and Development, the Journal of Multicultural Counseling and Development, Educational and Psychological Measurement, and the Harvard Educational Review.
Cokley has a joint appointment in the College of Education's Department of Educational Psychology and the College of Liberal Arts' Department of African and African Diaspora Studies. He is the Past Editor-in-Chief of the Journal of Black Psychology and the Director of the Institute for Urban Policy Research & Analysis.
He has written several Op-Eds in major media outlets including the St. Louis Post Dispatch, Dallas Morning News, San Antonio Express, The American Prospect, The Huffington Post, The Conversation and The Hill on topics such as Blacks' rational mistrust of police, police shootings of Blacks, the aftermath of Ferguson, the use of school vouchers, racial disparities in school discipline, and Black students' graduation rates.
"As we celebrate Black History Month, we should not fall prey to forces that seek to divide us. Remember that Black Lives Matter embraced the differences and diversity that have always characterized the black experience while intervening in violence inflicted on all-black communities.",“This is not the time or place for people to simply be a supporter in private. We need your voices; we need you to be just as outraged as those of us who are victimized by these acts of racism.”,“I think that that’s just a microcosm of the different experiences that we have in this country and so what I would want white people to understand is that before you start judging the behaviors of a group of people for whom you have not walked in their shoes or lived their experience, think about for a moment, what it might be like to actually have that experience and how your perspectives might impact change if you were to live the lives of the people that you're too quick to criticize.”
The sobering reality is that on any given day, for any given reason, black people in this country will be killed, often with impunity, for no other apparent reason than the fact that we are black.,"The curriculum that they will be taught will be important, it will be information that they've been exposed to that they need," said Dr. Cokley. "But, some of the elements that some of us believe are also very important, you know, will not be included."
Cosimo Commisso, Ph.D., studies pancreatic cancer, one of the deadliest cancers. He is particularly interested in how the tumor gets nutrients from its environment, as cutting this fuel supply could stop the cancer’s growth.
Nicole Coomber is on the faculty in the Management & Organization area at the Robert H. Smith School of Business. Dr. Coomber completed her PhD in Education Policy and Leadership in May of 2012 at the University of Maryland’s College of Education. Her research interests include leadership, team dynamics, and experiential learning. Dr. Coomber teaches a variety of courses including Managing People and Organizations, Leadership in Action, Non-Profit Consulting, and Cross-Cultural Challenges in Business. Before joining the faculty at Smith, she worked with the QUEST program leading efforts in curriculum and corporate development.
“Pay is a great thing to look at, but it’s just one piece of the whole compensation package,” said Nicole M. Coomber, associate clinical professor of management and organization at the University of Maryland’s Robert H. Smith School of Business.,"We know that when teams have high levels of trust and a feeling of safety, they are better performing," she said. "When you are open with colleagues, it helps them understand they can be honest, too."
Corbosiero studies the structure and intensity change of tropical cyclones using both observational data sets, such as aircraft reconnaissance, and lightning, and high-resolution numerical models. She is interested in understanding the physical processes responsible for the formation of hurricane rainbands and secondary eyewalls, and how tropical cyclones respond to, and evolve in, vertical wind shear.
In addition, Corbosiero is leading an ongoing research collaboration between the National Weather Service and UAlbany’s Department of Atmospheric and Environmental Sciences, which is providing valuable insights into extreme weather as it trains the next generation of forecasters. The project focuses on the occurrence and prediction of high-impact weather events in the Northeastern United States. Such events, which include damaging winds and hail, widespread and localized flooding, and heavy snow and ice accumulations, have the potential to cause substantial societal and economic disruption.
The research has shed light on such subjects as hurricane-related heavy rainfall, the distribution of small-scale heavy snow bands, and the processes that govern the occurrence and location of severe weather. Research findings are transferred directly into daily NWS forecasts and operations.
Dr. Larry Corey is an internationally renowned expert in virology, immunology and vaccine development, and the former president and director of the Fred Hutchinson Cancer Research Center in Seattle. For more than four decades, he has led some of the most significant advances in medicine, including the development of safe and effective antivirals for herpes, HIV and hepatitis infections. An international expert in the design and testing of vaccines, he is helping to formulate a global, strategic response to COVID-19.
Earlier this year, he responded to the sudden emergence of COVID-19 by redirecting his energies to speed the development of antiviral medications and vaccines against SARS-CoV-2, the virus responsible for the pandemic. He is building strategic collaborations among academic institutions, government health leaders and the pharmaceutical industry to test future COVID-19 vaccines and find ways to manufacture and distribute enough doses to immunize as many as 4 billion people.
Dr. Corey is drawing on his expertise as a co-founder, in 1998, of the HIV Vaccine Trials Network. Headquartered at Fred Hutch in Seattle, it is the world’s largest publicly funded collaboration focused on development of vaccines to prevent HIV/AIDS.
Dr. Corey's teaching and mentoring interests include virology, viral immunology and development of novel therapies for viral infections. His current research projects include:
- Spatial and functional characterization of tissue resident immune responses at the site of herpesvirus or HIV infection
- Development of immunotherapies for HSV and HIV infection; including CAR T cells for treatment for HIV infection
- Spatial dynamics and function of adoptively transferred or vaccine induced T cells
- Characterization of tissue-based memory B cells and the role antibody effector responses play in chronic viral infections
- Use of monoclonal antibodies for the prevention of viral infections
In addition to his role as president and director emeritus at Fred Hutch, Dr. Corey is a member of the Center's Vaccine and Infectious Disease, Clinical Research, and Public Health Sciences Divisions. He is also a Professor, Medicine and Laboratory Medicine at the University of Washington, and Principal Investigator at the HIV Vaccine Trials Network (HVTN).
“COVID-19 is a re-living of what happened 39 years ago in HIV, when it was difficult and frustrating,” he said. “The lesson that we learned then is that when the academic, biotech and pharmaceutical communities put their collective scientific assets together, things happen. Science is about resilience. You have to have optimism, resilience and perseverance.”,Many viruses, including HIV and hepatitis C, have thwarted vaccine developers. But the new coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), doesn’t appear to be a particularly formidable target. It changes slowly, which means it’s not very good at dodging the immune system, and vaccines against the related coronaviruses that cause SARS and Middle East respiratory syndrome (MERS) have worked in animal models. Corey heads the United States’s HIV Vaccine Trials Network, which has seen one candidate vaccine after another crash and burn, is optimistic about a SARS-CoV-2 vaccine. “I don’t think this is going to be tha
“This is a wonderful response from the biomedical community to an epidemic,” says Lawrence Corey, a virologist at the Fred Hutchinson Cancer Research Center who has run vaccine trials against a dozen diseases but is not involved with a COVID-19 effort. “
Dr. Costa's goal is to maximize survival and minimize morbidity for mechanically ventilated adults. She accomplishes this through her research on the organization and management of critical care. Specifically, her work identifies key structural and functional characteristics of ICU interprofessional teams that can be leveraged to improve the delivery of high quality, complex care to mechanically ventilated patients
Michele Cournan, DNP, RN, ANP-BC, FNP, CRRN has been a rehabilitation nurse for over 20 years with experience in acute rehabilitation and academia. She is currently the Director of Clinical Services at Sunnyview Rehabilitation Hospital, an acute free-standing rehabilitation facility in Schenectady, New York. She is also an adjunct faculty member at Excelsior College, a part-time faculty at Walden University, and has a private business as a legal nurse consultant. She has published several articles and delivered many presentations nationally over the past 15 years. Most recently Michele has presented webinars related to the care and management of COVID-19 patients in rehabilitation facilities. She has also presented a series of webinars nationally on the Impact Act and the resulting changes in the regulations for functional assessment. Michele is a Past-President of the Association of Rehabilitation Nurses.
Lisa W. Coyne, PhD, is an assistant professor of psychology in the Department of Psychiatry, part-time, at Harvard Medical School, and is a senior clinical consultant at the Child and Adolescent OCD Institute (OCDI Jr.) at McLean Hospital. She is also an associate clinical professor at Suffolk University in Boston, a licensed clinical psychologist, and an internationally recognized acceptance and commitment therapy (ACT) trainer.
Dr. Coyne has published numerous peer-reviewed articles and chapters on anxiety, OCD, and parenting. She is the author of The Joy of Parenting: An Acceptance and Commitment Therapy Guide to Effective Parenting in the Early Years, a book for parents of young children.
I have been working at the VA Medical Center and in the Department of Behavioral Neuroscience at the Oregon Health & Science University in Portland since 1979. I entered graduate school at the University of Colorado to obtain a Ph.D. in social psychology. Fortuitously, I was sidetracked into instead studying behavioral neuroscience (AKA biopsychology) at the fledgling Institute for Behavioral Genetics in Boulder. I’ve been pretty much surrounded by mice ever since. I did post-doctoral work at the University of Wisconsin-
Milwaukee and was a Lecturer in Psychology at San José State and then UC-Santa Barbara, and then held a two-year research position at a Dutch pharmaceutical company in the Dutch hinterlands before Portland.
My research interest is in understanding individual differences in behavioral susceptibility to alcohol and other drugs of abuse, and their genetic and neurobiological bases. Most recently, I’ve been breeding mice that voluntarily drink alcohol until they become intoxicated, i.e. developing a mouse model of university students. I’m working with collaborators to figure out how many genes we’ve affected in the process, which ones they are, and what their biological functions are. We’re using that information to try to predict some drugs that are already FDA approved that might be re-purposed to try as treatments for alcoholism. My expertise is in mouse behavioral tests that try to capture human traits such as anxiety, sensitivity to drug’s rewarding or aversive effects, incoordination, learning and memory, novelty-seeking, and so forth. I am less fluent in rat than in mouse but the languages are related.
I am familiar with psychiatric genetics/human genetics methods, but not really expert in the more esoteric of them. I am also familiar with the big data/genomics/informatics approaches, but again not really expert there, either.
Dr. Crotty received his B.S. in Biology from the Massachusetts Institute of Technology (MIT) in 1996. He also received a B.S. in Writing from MIT the same year. Dr. Crotty undertook graduate work in virology at the University of California, San Francisco in the Program in Biological Sciences. There he discovered the mechanism of action of the antiviral drug ribavirin, widely used to treat chronic hepatitis C infections. Dr. Crotty earned his Ph.D. in Biochemistry and Molecular Biology in 2001. He then pursued postdoctoral work at the Emory University Vaccine Center with Dr. Rafi Ahmed from 2001 to 2003, studying aspects of the generation and maintenance of immune memory after viral infections. In 2003, he accepted a faculty position at LJI.
The Crotty lab has helped established that follicular helper T cells (Tfh) are a distinct type of differentiated CD4 T cell uniquely specialized in B cell help, and that Tfh differentiation is controlled by the transcription factor Bcl6 (Science 2009). He has made major advances in the area of T cell help to B cells, and through this work has become an internationally recognized leader in the field of Tfh cell biology (Annual Review of Immunology 2011). Dr. Crotty was named a Pew Scholar in Biomedical Sciences in 2005, and was the recipient of the annualAmerican Association of Immunologists (AAI) Investigator Award for outstanding early-career research contributions to the field of Immunology in 2012.
Dr. Crotty is also the author of Ahead of the Curve, a biography of Nobel laureate scientist David Baltimore, published in 2001, and reviewed in The Wall Street Journal, Nature, The Washington Post, The Journal of the American Medical Association (JAMA), Nature Medicine, and Discover Magazine.
"Infectious diseases kill more people worldwide than any other single cause. That’s one of the main reasons I focus on vaccines. They really have the potential for improving lives and saving lives."
Understanding what takes place will help researchers determine how well new HIV vaccines are guiding the immune response, said vaccine researcher Shane Crotty of the La Jolla Institute for Allergy & Immunology, a lead author of the study.,“Vaccine development still relies primarily on trial and error and vaccine candidates either work or fail,” says Dr. Crotty. “That’s a really inefficient way of making progress. What we really want is to turn it into an engineering problem.”
The National SEED Project (Seeking Educational Equity and Diversity) partners with schools, organizations, and communities to develop leaders who guide their peers in conversational communities to drive personal, organizational, and societal change toward social justice. As co-director of the National SEED Project, Gail Cruise-Roberson supports New York City-area educators and community leaders who run their own year-long, school-based SEED seminars in order to drive social change.
Throughout her career, Cruise-Roberson has worked in public education reform and adult education in New York City, Newark, NJ, and Chicago, Il. In 1999, Cruise-Roberson began working to train diversity facilitators -- teachers as well as high school students and parents -- to lead their own year-long seminars with the Minnesota Inclusiveness Project. In 2008, she joined the staff at the National SEED Project and co-facilitated SEED seminars in California.
She has a B.A. in English and graduate work in communications from Queens College (CUNY), with a focus on small group communication.
Dr. Crutchfield, a nationally known expert on concussions and traumatic brain injury, directs LifeBridge Health’s Comprehensive Sports Concussion Program. He has served as an independent neurologist for many professional sports leagues and is board certified in psychiatry and neurology. He is a faculty appointee at the Uniformed Services University of Health Sciences and is a researcher and consultant to the U.S. military regarding the effects of traumatic brain injuries.
As the founding executive director of UCI’s multidisciplinary Cybersecurity Policy & Research Institute, Bryan Cunningham is focused on solution-oriented strategies that address technical, legal and policy challenges to combat cyber threats; protect individual privacy and civil liberties; maintain public safety, economic and national security; and empower Americans to take better control of their digital security.
Cunningham is a leading international expert on cybersecurity law and policy, a former White House lawyer and adviser and a media commentator on cybersecurity, technology and surveillance issues. He has appeared on ABC, Bloomberg, CBS, CNN, FOX and other networks.
Cunningham has extensive experience in senior U.S. government intelligence and law enforcement positions. He served as Deputy Legal Adviser to then-National Security Advisor Condoleezza Rice. He also served six years in the Clinton administration as a senior CIA officer and federal prosecutor. He drafted significant portions of the Homeland Security Act and related legislation, helping to shepherd them through Congress. He was a principal contributor to the first National Strategy to Secure Cyberspace, worked closely with the 9/11 Commission and provided legal advice to the President, National Security Advisor, the National Security Council, and other senior government officials on intelligence, terrorism, cyber security and other related matters.
Cunningham is a founding partner of the Washington, DC-Los Angeles firm Cunningham Levy Muse, and his law practice has included assisting Fortune 500 and multinational companies to comply with complex legal regulations under U.S. federal law, myriad state laws and the numerous privacy and security requirements in the European Union and other overseas jurisdictions.
He was founding vice-chair of the American Bar Association Cyber Security Privacy Task Force and was awarded the National Intelligence Medal of Achievement for his work on information issues. He has served on the National Academy of Sciences Committee on Biodefense Analysis, the Markle Foundation Task Force on National Security in the Information Age and the Bipartisan Policy Center’s Cyber Security Task Force. He is also the principal author of legal and ethics chapters in several cybersecurity textbooks.